Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...

January 20, 2026 • It's unclear how many leaders have been asked to join the board, and the large number of invitations being sent out, including to countries that don't get along, has raised ...